… Hochberg has received consultant fees (less than $10,000 each) from Abbott Laboratories,
Amgen… Hochberg had full access to all of the data in the study and takes responsibility for the …

PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert
consensus recommendations for the management of hip and knee osteoarthritis (OA), which are …

OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 January …

For the purposes of classification, it should be specified whether osteoarthritis (OA) of the
knee is of unknown origin (idiopathic, primary) or is related to a known medical condition or …

… : comment on the letter by Hochberg." Arthritis Rheum. 1998 Jul; 41 (7): 1326-7. …
erythematosus: comment on the letter by Hochberg." Arthritis Rheum. 1998 Apr; 41 (4): 751. …

Objective. To standardize outcome measures in systemic lupus erythematosus (SLE). Three
indices were identified which could adequately describe outcome (disease activity, damage …

Objective To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by osteoarthritis, polymyalgia rheumatica and giant cell …

Clinical criteria for the classification of patients with hip pain associated with osteoarthritis (OA)
were developed through a multicenter study. Data from 201 patients who had …

Background Each year, clinical upper gastrointestinal events occur in 2 to 4 percent of patients
who are taking nonselective nonsteroidal antiinflammatory drugs (NSAIDs). We assessed …

… real-valued matrix (M) may be decomposed as M = UΣV † through singular value decomposition
(SVD) 25 , where U is an m × m unitary matrix, Σ is an m × n rectangular diagonal matrix …